Entera Bio (ENTX) Earnings Analysis

Entera Bio (ENTX) next reports earnings on 2026-08-14, consensus EPS -0.08 USD. Last quarter (2026-05-08) it beat with EPS -0.07 USD vs -0.08 USD est (+12.5%). It has beaten estimates in 6/7 recent quarters (86%). Trailing P/E -7.71.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does ENTX next report earnings?

Next earnings date2026-08-14
Consensus EPS estimate-0.08 USD
Revenue estimaten/a

ENTX earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-08-0.07 USD-0.08 USD+12.5%Beat
2026-03-27-0.07 USD-0.09 USD+22.2%Beat
2025-11-14-0.07 USD-0.09 USD+22.2%Beat
2025-08-08-0.06 USD-0.11 USD+45.5%Beat
2025-05-09-0.06 USD-0.07 USD+14.3%Beat
2024-11-08-0.08 USD-0.05 USD-60%Miss
2024-08-09-0.06 USD-0.06 USD0%Beat

Beat rate: 6/7 (86%) over reported quarters with consensus data.

ENTX valuation and analyst view

Trailing P/E-7.71
Trailing EPS-0.25917 USD
Price / book9.07
Dividend yield0.00%
Market cap0.10B
Analyst consensusBuy (4 buy / 0 hold / 0 sell)

Related research pages

Frequently asked questions

When is Entera Bio (ENTX)'s next earnings date?

Entera Bio is next scheduled to report on 2026-08-14, with a consensus EPS estimate of -0.08 USD.

Did ENTX beat earnings last quarter?

In its 2026-05-08 report, ENTX posted EPS of -0.07 USD versus a -0.08 USD estimate — a beat of 12.5%.

What is ENTX's earnings track record?

Over the last 7 reported quarters with consensus data, ENTX beat estimates 6 times (86%).

What is ENTX's current P/E ratio and EPS?

ENTX trades at a trailing P/E of -7.71 on trailing EPS of -0.25916940279157086 USD.

What do analysts rate ENTX?

Analyst consensus is "Buy" across 4 ratings (0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell).